AT4 receptor is insulin-regulated membrane aminopeptidase: Potential mechanisms of memory enhancement

Trends in Endocrinology and Metabolism

Volumn 14, Issue 2, 2003, Pages 72-77

  Albiston, Anthony L ^a   Mustafa, Tomris ^a   McDowall, Sharon G ^a   Mendelsohn, Frederick A O ^a   Lee, Joohyung ^a   Chai, Siew Yeen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN 4 RECEPTOR; ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR; HEXAPEPTIDE; INSULIN REGULATED MEMBRANE AMINOPEPTIDASE; UNCLASSIFIED DRUG; ANGIOTENSIN II; ANGIOTENSIN II, DES ASP(1) DES ARG(2) ILE(5); ANGIOTENSIN II, DES-ASP(1)-DES-ARG(2)-ILE(5)-; AT4 RECEPTOR; CYSTYL AMINOPEPTIDASE; DRUG DERIVATIVE; GLUCOSE; INSULIN; LEUCYL CYSTINYL AMINOPEPTIDASE; LEUCYL-CYSTINYL AMINOPEPTIDASE;

FACILITATION; GLUCOSE TRANSPORT; LEARNING; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; DRUG EFFECT; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; TISSUE DISTRIBUTION;

AMINOPEPTIDASES; ANGIOTENSIN II; ANIMALS; BRAIN; CYSTINYL AMINOPEPTIDASE; GLUCOSE; HUMANS; INJECTIONS, INTRAVENTRICULAR; INSULIN; MEMORY; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0038407755     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00037-1     Document Type: Review

References (65)

1. Stroth, U. and Unger, T. (1999) The renin-angiotensin system and its receptors. J. Cardiovasc. Pharmacol. 33, S21-S28
2. Wright, J.W. et al. (1995) The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16, 23-52
3. Santos, R.A. et al. (2000) Angiotensin-(1-7): an update. Regul. Pept. 91, 45-62
4. Reaux, A. et al. (2001) Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol. Metab. 12, 157-162
5. de Gasparo, M. et al. (1995) Proposed update of angiotensin receptor nomenclature. Hypertension 25, 924-927
6. Harding, J.W. et al. (1992) Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus. Brain Res. 583, 340-343
7. 4 receptor in a human neuroblastoma cell line (SK-N-MC). J. Neurochem. 76, 1679-1687
8. 4 receptor in the brain. J. Neurochem. 68, 2530-2537
9. Chai, S.Y. et al. (2000) Distribution of angiotensin IV binding sites (AT(4) receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography. J. Chem. Neuroanat. 20, 339-348
10. Moeller, I. et al. (1995) Localization of angiotensin IV binding sites to motor and sensory neurons in the sheep spinal cord and hindbrain. Brain Res. 701, 301-306
11. 4 receptors in the Macaca fascicularis brain, Brain Res. 712, 307-324
12. Miller-Wing, A.V. et al. (1993) Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J. Pharmacol. Exp. Ther. 266, 1718-1726
13. Wright, J.W. et al. (1995) The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16, 23-52
14. Braszko, J.J. et al. (1988) Angiotensin II (3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27, 777-783
15. Wright, J.W. et al. (1993) Angiotensin II (3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Res. Bull. 32, 497-502
16. 4 receptor subtype system to spatial learning. J. Neurosci. 19, 3952-3961
17. Pederson, E.S. et al. (1998) Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. Regul. Pept. 74, 97-103
18. 4 receptor distribution in mouse brain and its possible role in facilitation of spatial memory. J. Neurochem. 78, 15
19. Wayner, M.J. et al. (2001) Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides 22, 1403-1414
20. Kramar, E.A. et al. (2001) The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res. 897, 114-121
21. Lee, J. et al. (2001) Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology 40, 618-623
22. Moeller, I. et al. (1996) Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones. Brain Res. 725, 61-66
23. Krebs, L.T. et al. (1996) Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist. Regul. Pept. 67, 123-130
24. 4) receptor is the enzyme insulin regulated aminopeptidase. J. Biol. Chem. 276, 48623-48626
25. Keller, S.R. et al. (1995) Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. J. Biol. Chem. 270, 23612-23618
26. Rogi, T. et al. (1996) Human placental leucine aminopeptidase/ oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family. J. Biol. Chem. 271, 56-61
27. Matsumoto, H. et al. (2000) Characterization of a recombinant soluble form ofhuman placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur. J. Biochem. 267, 46-52
28. Herbst, J.J. et al. (1997) Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. Am. J. Physiol. 272, E600-E606
29. Kovacs, G.L. and De Wied, D. (1994) Peptidergic modulation of learning and memory processes. Pharmacol. Rev. 46, 269-291
30. Alescio-Lautier, B. et al. (2000) Neuromodulation of memory in the hippocampus by vasopressin. Eur. J. Pharmacol. 405, 63-72
31. Paban, V. et al. (1997) Effects of arginine8-vasopressin administered at different times in the learning of an appetitive visual discriminative task in mice. Behav. Brain Res. 87, 149-157
32. Fujiwara, M. et al. (1997) Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats. Behav. Brain Res. 83, 91-96
33. Cacabelos, R. et al. (1988) Influence of somatostatin and growth hormone-releasing factor on behavior. Clinical and therapeutic implications in neuropsychiatric disorders. Horm. Res. 29, 129-132
34. Lamirault, L. et al. (2001) Intrahippocampal injections of somatostatin dissociate acquisition from the flexible use of place responses. Eur. J. Neurosci. 14, 567-570
35. Matsuoka, N. et al. (1994) Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Brain Res. 642, 11-19
36. Matsuoka, N. et al. (1995) Changes in brain somatostatin in memory deficient rats: comparison with cholinergic markers. Neuroscience 66, 617-626
37. Itoh, S. et al. (1987) Interactions of cholecystokinin, β-endorphin, and their antagonists on passive avoidance behavior in rats. Can. J. Physiol. Pharmacol. 65, 2260-2264
38. Flood, J.F. and Morley, J.E. (1989) Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides. Peptides 10, 809-813
39. Ladurelle, N. et al. (1997) The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats. Eur. J. Neurosci. 9, 1804-1814
40. Nikolova, J.G. et al. (2000) Effects of ACE-inhibitors on learning and memory processes in rats. Folia Med. (Plovdiv) 42, 47-51
41. Raghavendra, V. et al. (2001) Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides 35, 65-69
42. Ferder, L.F. et al. (2002) Advances in our understanding of aging: role of the renin-angiotensin system. Curr. Opin. Pharmacol. 2, 189-194
43. Hirawa, N. et al, (1999) Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension 34, 496-502
44. Toide, K. et al. (1997) A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease. Behav. Brain Res. 83, 147-151
45. Toide, K. et al. (1995) JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. J. Pharmacol. Exp. Ther. 274, 1370-1378
46. Bryant, N.J. et al. (2002) Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 3, 267-277
47. Pessin, J.E. et al. (1999) Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!. J. Biol. Chem. 274, 2593-2596
48. Apelt, J. et al. (1999) Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J. Neurosci. Res. 57, 693-705
49. Gold, P.E. (1995) Modulation of emotional and nonemotional memories: same pharmacological systems, different neuroanatomical systems. In Brain and Memory: Modulation of Neuroplasticity (McGaugh, J.L. et al., eds), pp. 41-74, Oxford University Press
50. Ragozzino, M.E. et al. (1996) Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc. Natl Acad. Sci. U.S.A. 93, 4693-4698
51. Wickelgren, I. (1998) Tracking insulin to the mind. Science 280, 517-519
52. Kopf, S.R. et al. (2001) Glucose plus choline improve passive avoidance behaviour and increase hippocampal acetylcholine release in mice. Neuroscience 103, 365-371
53. Johnson, A.O. et al. (2001) A di-leucine sequence and a cluster of acidic amino acids are required for dynamic retention in the endosomal recycling compartment of fibroblasts. Mol. Biol. Cell 12, 367-381
54. Waters, S.B. et al. (1997) The amino terminus of insulin-responsive aminopeptidase causes Glut4 translocation in 3T3-L1 adipocytes. J. Biol. Chem. 272, 23323-23327
55. Sbodio, J.I. and Chi, N.W. (2002) Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RxxPDG motif and is a novel tankyrase partner. J. Biol. Chem. 277, 31887-31892
56. Chi, N.W. and Lodish, H.F. (2000) Tankyrase is a Golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J. Biol. Chem, 275, 38437-38444
57. Katagiri, H. et al. (2002) Acyl-coenzyme A dehydrogenases are localized on GLUT4-containing vesicles via association with insulin-regulated aminopeptidase in a manner dependent on its dileucine motif. Mol. Endocrinol. 16, 1049-1059
58. Ryu, J. et al. (2002) Protein kinase C-ζ phosphorylates insulin-responsive aminopeptidase in vitro at Ser-80 and Ser-91, Arch. Biochem. Biophys. 403, 71-82
59. Dostal, D.E. et al. (1990) Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension 15, 815-822
60. Dulin, N. et al. (1995) Angiotensin IV receptors and signaling in opossum kidney cells. Am. J. Physiol. 269, F644-F652
61. 2+ in mesangial cells. Eur. J. Pharmacol. 414, 165-175
62. Handa, R.K. et al. (1999) Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands. J. Pharmacol. Exp. Ther. 291, 1242-1249
63. 4 receptor in human proximal tubule epithelial (HK-2) cells. J. Am. Soc. Nephrol. 12, 440-449
64. Patel, J.M. et al. (1999) Increased expression of calreticulin is linked to ANG IV-mediated activation of lung endothelial NOS. Am. J. Physiol. 277, L794-L801
65. Chen, J.K. et al. (2001) Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am. J. Physiol. Renal Physiol. 280, F980-F988